Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies

INTRODUCTION: The purpose of this study is to investigate the effects of agomelatine on anxious symptoms and functional impairment in a pooled dataset from randomized placebo-controlled trials for generalized anxiety disorder (GAD). METHODS: Data from three randomized, placebo-controlled trials that...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Dan J., Khoo, Jon-Paul, Picarel-Blanchot, Françoise, Olivier, Valérie, Van Ameringen, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932987/
https://www.ncbi.nlm.nih.gov/pubmed/33537871
http://dx.doi.org/10.1007/s12325-020-01583-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932987/
https://www.ncbi.nlm.nih.gov/pubmed/33537871
http://dx.doi.org/10.1007/s12325-020-01583-9

Ejemplares similares